𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of the p53 gene in male breast cancer

✍ Scribed by Agnaldo Anelli; Tǎnia F. M. Anelli; Bruce Youngson; Paul P. Rosen; Patrick I. Borgen

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
609 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms in drug metabolism genes,
Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer
✍ Beth O. Van Emburgh; Jennifer J. Hu; Edward A. Levine; Libyadda J. Mosley; L. Do 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo

Mutational analysis of the p73 Gene in h
Mutational analysis of the p73 Gene in human breast cancers
✍ Tomotane Shishikura; Shingo Ichimiya; Toshinori Ozaki; Yoshinori Nimura; Hajime 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB 👁 2 views

In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region

P53 gene mutations and steroid receptor
P53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment
✍ Maira Caleffi; Mark W. Teague; Roy A. Jensen; Cindy L. Vnencak-Jones; William D. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 880 KB

Background. There is increasing evidence linking development and progression of cancer to an accumulation of mutations at the genomic level. The most frequently mutated gene known to date in sporadic breast cancer appears to be the tumor suppressor gene p53. This study was designed to determine the

Functional analysis of p53 gene and the
Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer
✍ Noriaki Sakuragi; Hidemichi Watari; Yasuhiko Ebina; Ritsu Yamamoto; Eric Steiner 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 182 KB 👁 1 views

## Abstract In addition to the loss of function, mutant p53 can possess a dominant‐negative effect on wild‐type p53 and may also exert gain‐of‐function activity. It is not clear whether the functional status of __p53__ mutation contributes to differences in outcome in endometrial cancer. We collect